Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06512389
PHASE2

Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder

Sponsor: Centre for Addiction and Mental Health

View on ClinicalTrials.gov

Summary

This human laboratory study aims to assess the effects of cannabidiol on alcohol consumption and craving in participants with alcohol use disorder. In this double-blind within-subject placebo-controlled crossover trial, participants will be randomized to receive both cannabidiol and placebo with a 2-week washout period separating the two treatment phases.

Official title: Evaluating Cannabidiol as a Novel Anticraving Medication for Alcohol Use Disorder: A Human Laboratory Study

Key Details

Gender

All

Age Range

19 Years - Any

Study Type

INTERVENTIONAL

Enrollment

36

Start Date

2024-08-16

Completion Date

2026-06-30

Last Updated

2026-03-20

Healthy Volunteers

No

Interventions

DRUG

Oral solution

300 mg taken morning and evening

Locations (1)

Centre for Addiction and Mental Health

Toronto, Ontario, Canada